Please Wait...

Classic Blog

The Future Development of Imaging Biomarkers

  • 0
  • 22 Jun
An imaging biomarker is a quantifiable anatomic, physiologic or metabolic parameter derived from an image that is an indicator of a particular disease. Furthermore a biomarker is a parameter which can be used at an indicator of the progression of a disease or medical condition or the effect of treatment. A number of public-private partnerships are working together to develop novel imaging biomarkers. One of these is the Alzheimer's Disease Neuroimaging Initiative (ADNI). A few years ago the ADNI started a clinical trial (ADN1-1) that involved 57 sites with 200 normal subjects followed for three years, 400 subjects with mild cognitive impairment (MCI) followed for 2 years and 200 subjects with Alzheimer's disease (AD) followed for 2 years. Participants receive clinical exams, cognitive tests with some also having FDG-PET and PiB-PET. The aim was to gather longitudinal data over time and link early cognitive, imaging and biomarker changes to later clinical decline.
Read More

How Will the Stimulus Package Affect Clinical Research?

  • 0
  • 10 Jun

To borrow from Oprah, here is what I know for sure:

Read More

With Good Clinical Trial Technology, Why Is Data Still Double Entered?

  • 0
  • 09 Jun

That's just the first in a long series of persistent questions in the clinical trial industry. Why don't we have one consolidated place to see all information regarding a specific region, site, or patient? How come every clinical trial seems to use different terminology and disparate applications (resulting in a new learning curve and low user adoption)? Why can't we get ad-hoc reports in a format that is actually useful, covering a timeframe we actually care about?

Read More

The Use of Imaging Technologies to Improve the Flavor of Lamb

  • 0
  • 03 Jun
A few weeks ago while attending the International Osteoporosis Foundation (IOF) World Congress in Florence, I had some of the best lamb I have ever tasted at a recommended restaurant. So good, in fact, that the local chefs ate there as well at the end of their evening. It turned out the restauranteur owned a sheep farm.
Read More

Pages

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @lauren_chazal: Talking about metrics at MAGI East! @bioclinica #magieast2017 #magi17 https://t.co/vfsvbqbMnF
bioclinica (10 hours ago)
We have an incredibly experienced and motivated team focused on accelerating our ability to do what’s... https://t.co/HjjLpn7aAN
bioclinica (12 hours ago)
Industry latest via CenterWatch News Online https://t.co/hgyMUAL1oZ
bioclinica (15 hours ago)
RT @lauren_chazal: Envisioning e-research in 2020 #magi2017 @bioclinica https://t.co/SOvp0Cttia
bioclinica (15 hours ago)
[blog] A primer on #Biomarkers in #ClinicalResearch https://t.co/3rmy3rnKFb
bioclinica (3 days ago)
RT @ACRPDC: Happy #clinicaltrialsday! Join the celebration by telling us what you are doing as a #clinicalresearch professional. https://t.…
bioclinica (3 days ago)

Latest Blogs: